5 August 2024
Windar Photonics plc
("Windar Photonics" or the "Company")
AGM Trading Update
Windar Photonics plc (AIM: WPHO), the technology group that has developed its WindEye and WindTimizer LiDAR wind sensors and its related 'Nexus' software suite designed to efficiently and cost effectively increase the power output and reduce lifetime operating costs of electricity generating wind turbines, gives an update ahead of the Company's AGM later today.
Windar Photonics provided a trading update, alongside the 2023 final results announcement, on 1st July. Since then, the Company has received a new order from a Canadian client to test our WindEye product on the Senvion turbine platform, starting in September. While the value of this test order, which includes the use of supporting software, is not in itself material, the Board anticipates that if the test is successful, this could lead to potentially significant new orders.
We continue to be in discussions with numerous operators in North America regarding orders for multiple turbine platforms and our view of the order outlook in Japan, Australia and China remains optimistic. The Board looks forward to providing a further update on progress with our interim results in the autumn.
For further information, please visit www.investor.windarphotonics.com or contact:
| Windar Photonics plc | |
| Jørgen Korsgaard Jensen, CEO Gavin Manson | Tel: +45 24234930 |
| | |
|
|
|
| Grant Thornton UK LLP Nominated Adviser |
|
| Philip Secrett / Harrison Clarke / Elliot Peters | Tel: +44 (0) 20 7383 5100 |
| | |
| Dowgate Capital Broker | |
| James Serjeant / Russell Cook | Tel: +44 (0) 20 3903 7715 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
